FDA to rule Monday on Copaxone competitor - Globes
Links shared publicly online about this topic.
- 476total visits
FDA to rule Monday on Copaxone competitor - Globes
FDA to rule Monday on Copaxone competitor - Globes
View full resource at globes.co.il
Tags: Multiple Sclerosis Medication, FDA, Copaxone, Merck & Co., Merck KGaA
Most Recently Shared on February 27, 2011 at 2:23 pm By:
FDA to rule Monday on Copaxone competitor: Teva expects the FDA to reject Merck KGaA's application for a multipl... http://bit.ly/dKH3gS
Teva Rises on Bets FDA Ruling Will Slow Competition - Bloomberg
bloomberg.com — “Teva Pharmaceutical Industries Ltd. climbed the most in more than two weeks on speculation failure by the company to win U.S. approval for a new formulation of its multiple sclerosis drug Copaxone means it will be more difficult for competitors to enter the market.” View full resource at bloomberg.com
Most Recently Shared on December 27, 2010 at 3:58 pm By:
Bloomberg: Teva Pharma Rises on Optimism of Reduced Competition for Copaxone MS Drug. http://bit.ly/h8S6SD
Advertisement
